about
RETRACTED: Inactivation of MAP kinase signalling in Myc transformed cells and rescue by LiCl inhibition of GSK3.Viral mutations enhance the Max binding properties of the vMyc b-HLH-LZ domain.Functional interactions among members of the MAX and MLX transcriptional network during oncogenesisComparison of antiviral activity of lambda-interferons against HIV replication in macrophagesProtein kinase A regulates MYC protein through transcriptional and post-translational mechanisms in a catalytic subunit isoform-specific manner.Immortalization of human neural stem cells with the c-myc mutant T58A.The c-Myc transactivation domain is a direct modulator of apoptotic versus proliferative signals.Abnormal expression of REST/NRSF and Myc in neural stem/progenitor cells causes cerebellar tumors by blocking neuronal differentiation.Characterization of Apoptosis Signaling Cascades During the Differentiation Process of Human Neural ReNcell VM Progenitor Cells In Vitro.Targeted suicide gene therapy for glioma using human embryonic stem cell-derived neural stem cells genetically modified by baculoviral vectors.v-Myc inhibits C/EBPbeta activity by preventing C/EBPbeta-induced phosphorylation of the co-activator p300.A novel, immortal, and multipotent human neural stem cell line generating functional neurons and oligodendrocytes.Acutely transforming avian leukosis virus subgroup J strain 966: defective genome encodes a 72-kilodalton Gag-Myc fusion proteinCalpain activity is generally elevated during transformation but has oncogene-specific biological functionsTransforming ability of Gag-Myc fusion proteins correlates with Gag-Myc protein stability and transcriptional repression.Metabolic Regulation of T Cell Immunity.
P2860
Q24805649-505CE511-D8C8-4583-A767-BD3F332AE821Q24815194-81F5B047-7A40-4673-91FD-23D8A76A6D91Q26853567-69EF75EC-255E-49E2-8CDE-942A0D50CD9FQ27307732-140B76A1-2EF0-4A60-9516-EF6B15601CE3Q30413042-2CC961B9-4945-4F5C-A287-2D7CEC16B15EQ33374007-3B66661E-15AD-43A0-A447-1995A5EA2FB2Q33963949-91AD6FE4-2C44-49E4-9400-76B3E7F48DAFQ34519687-CCCC1FD1-2ABE-4978-BBD1-436C5FE237D4Q38869779-37167ED8-7BD7-42E0-A10F-D3408AEAC8F9Q39531933-39FBCA80-56C4-4C2C-99CA-DE90A2D8AF4BQ39850190-245D89EE-DB81-4546-87F8-180F693A5114Q40122353-0773A51A-3816-4D60-B82C-2E74AE95346CQ40814875-666351AB-060A-4EF5-B88B-1C19DA9E4292Q42214621-CCB76FBA-A0F0-468E-96D3-88A53980BABCQ47618860-8C917920-5282-407F-BD1B-DB905E9A22CAQ50217787-F4A48902-8EE1-4678-BC28-E841EA73E249
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
The v-myc oncogene.
@ast
The v-myc oncogene.
@en
type
label
The v-myc oncogene.
@ast
The v-myc oncogene.
@en
prefLabel
The v-myc oncogene.
@ast
The v-myc oncogene.
@en
P2860
P356
P1433
P1476
The v-myc oncogene
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.ONC.1202786
P407
P577
1999-05-01T00:00:00Z
P5875
P6179
1014649767